Gerresheimer, an innovative systems and solutions provider and global partner to the pharma, biotech and cosmetics industries, is presenting its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions for the first time together with Bormioli Pharma at this year’s Pharmapack. The focus of the trade show appearance in Paris on 22 and 23 January 2025 will be on the further expanded portfolio of containment solutions with numerous closure options and accessories following the acquisition of Bormioli Pharma.
At the event, Gerresheimer will be presenting specialized primary packaging solutions and delivery systems for sensitive biologics, including EZ-fill Smart, the next-generation packaging platform for RTF vials and cartridges. Gerresheimer experts will also be available in the ‘Learning Lab’ to provide insights into current trend topics. In the Innovation Gallery, Gerresheimer will give a sneak preview of an exciting solution for adherence support in clinical trials using a digitally connected container for solid drugs. Gerresheimer and Bormioli Pharma will be showcasing their portfolio at Pharmapack at booth F55.
Under the motto ‘Two Stories – One Future’, Gerresheimer and Bormioli Pharma are presenting together at Pharmapack for the first time, after Gerresheimer’s successful completion of the Bormioli Pharma acquisition in December 2024. Pharmaceutical companies will benefit from an even wider range of containment solutions with suitable closure options and accessories, sustainable product lines and the combined innovative strength of both companies.
Special solutions for biologics
The focus of the trade show appearance will be on primary packaging solutions specially tailored to the requirements of sensitive biologics. With Gx Elite syringes, cartridges and vials, for example, Gerresheimer offers the highest quality and the best protection for injectable drugs. With EZ-fill Smart, Gerresheimer presents the next generation packaging platform for ready-to-fill (RTF) primary packaging such as vials and cartridges.
Both the outstanding product quality of the Gx Elite Performance Level and the innovative new packaging platform are designed to provide the best possible protection for particularly sensitive and expensive drugs such as novel biologics and to enable efficient, smooth filling.
Trend towards therapy at home
With the Gx Inbeneo auto-injector and the Gx SensAir on-body drug delivery device, Gerresheimer is also addressing the trend towards home therapy. Both devices enable simple, patient-friendly application with high-precision dosing of the respective medication. The on-body drug delivery device can optionally be digitally connected and integrated into digital health platforms.
Sneak-Preview Gx Cap for adherence support in clinical trials
In the Innovation Gallery (F12), Gerresheimer will provide a first glimpse at an exciting new digital solution for adherence support in clinical trials. Sueyoung Yoon of Gerresheimer will briefly present the solution on 23 January at 11:40am in the Innovation Gallery: Adherence to therapy is crucial to the success of clinical trials. If medication is not taken as intended, this could affect data integrity, trial efficiency and the safety of trial participants.
Gx Cap for Clinical Trials is a digitally connected tablet container cap, which enables the monitoring of oral medication intake so that trial participants can be reminded to take their medication if necessary. Gx Cap is already being used successfully by pharmacies in the USA for remote therapeutic monitoring programs for certain therapeutic areas.
Gerresheimer conference highlights in the Learning Lab
Gerresheimer experts will be giving three presentations in the Learning Lab and Sustainability Theater at Pharmapack to provide insights and expertise to the interested public:
Reducing the Carbon Footprint of our Products – Renewable Energy and Material Innovation as Viable Solutions
22 January 2025, 12:55pm to 1:25pm
Sustainability Theater K85
Speaker: Adrian Johnson (Gerresheimer)
A Partnership Worth More Than the Sum of Its Parts – Device Component Manufacturers Fulfil Syringe and System Performance Requirements
23 January 2025, 10:10am to 10:40am
Learning Lab K3
Speakers: Sébastien Cordier (Aptar Pharma), Lucy Lee (SHL Medical), Bernd Zeiss (Gerresheimer)
The innovation journey: Developing EZ-fill Smart as the New Industry Standard for Ready-to-Use Vials
23 January 2025, 2:30pm to 3:00pm
Learning Lab K3
Speaker: Holger Krenz (Gerresheimer)
Gerresheimer and Bormioli Pharma at Pharmapack Paris
Gerresheimer and Bormioli Pharma will be presenting their portfolio at Pharmapack in Paris on 22 and 23 January 2025 at booth F55. To make an appointment with one of our experts, please click here.